Summary of Study ST001301

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000882. The data can be accessed directly via it's Project DOI: 10.21228/M8PD88 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001301
Study TitleLuminal metabolome profiles of human microbiota-associated (HMA) mice treated with anti-IL-22 antibody or control antibody
Study SummaryLuminal (fecal) metabolome of anti-IL-22 antibody-treated HMA mice and control antibody-treated HMA mice were compared.
Institute
University of Michigan
DepartmentInternal Medicine
Last NameKamada
First NameNobuhiko
Address1150 W Medical center Dr, Ann Arbor, MI 48109, USA
Emailnkamada@umich.edu
Phone+1-734-763-2142
Submit Date2019-12-22
Raw Data AvailableYes
Raw Data File Type(s)d
Analysis Type DetailLC-MS
Release Date2020-01-08
Release Version1
Nobuhiko Kamada Nobuhiko Kamada
https://dx.doi.org/10.21228/M8PD88
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR001390
Treatment Summary:GF C57BL/6 mice were colonized with HC microbiotas for 2 weeks. After colonization of HC microbiota, the mice were treated with control or anti-IL-22 antibody twice (day -5 and day -3) before collecting fecal samples.
  logo